NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹62 Cr | ₹66 Cr | ₹71 Cr | ₹85 Cr | ₹96 Cr |
What is the latest Long Term Provisions ratio of NATCO PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹62 Cr |
| Mar2025 | ₹66 Cr |
| Mar2024 | ₹71 Cr |
| Mar2023 | ₹85 Cr |
| Mar2022 | ₹96 Cr |
How is Long Term Provisions of NATCO PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹62 Cr | -5.79 | |
| Mar2025 | ₹66 Cr | -7.48 | |
| Mar2024 | ₹71 Cr | -16.88 | |
| Mar2023 | ₹85 Cr | -10.87 | |
| Mar2022 | ₹96 Cr | - | |
Compare Long Term Provisions of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,710.7 Cr | -1.9% | -2.7% | -6.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -1.9% |
-2.7% |
-6.3% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses